HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

David A Morrow Selected Research

Acute Coronary Syndrome

10/2015Prognostic performance of a high-sensitivity assay for cardiac troponin I after non-ST elevation acute coronary syndrome: Analysis from MERLIN-TIMI 36.
8/2015Effects of Ranolazine in Patients With Chronic Angina in Patients With and Without Percutaneous Coronary Intervention for Acute Coronary Syndrome: Observations From the MERLIN-TIMI 36 Trial.
5/2015Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial.
1/2015Effect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial.
7/2014Relation of T-wave alternans to mortality and nonsustained ventricular tachycardia in patients with non-ST-segment elevation acute coronary syndrome from the MERLIN-TIMI 36 trial of ranolazine versus placebo.
6/2014Clinical features, use of evidence-based therapies, and cardiovascular outcomes among patients with chronic kidney disease following non-ST-elevation acute coronary syndrome.
6/2014ECG morphological variability in beat space for risk stratification after acute coronary syndrome.
4/2014Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).
4/2014Autoantibodies to phosphorylcholine and cardiovascular outcomes in patients with acute coronary syndromes in the ATLAS ACS-TIMI 46 trial.
1/2014Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndrome.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


David A Morrow Research Topics

Disease

103Myocardial Infarction
11/2015 - 06/2002
103Acute Coronary Syndrome
10/2015 - 02/2002
33Ischemia
08/2015 - 09/2004
25Heart Failure
08/2015 - 05/2004
20Hemorrhage
11/2015 - 04/2005
20Coronary Artery Disease (Coronary Atherosclerosis)
02/2014 - 11/2002
14Unstable Angina
03/2013 - 06/2002
13Stroke (Strokes)
11/2015 - 06/2007
12Atherosclerosis
03/2015 - 11/2004
11Cardiovascular Diseases (Cardiovascular Disease)
11/2013 - 09/2004
10Myocardial Ischemia (Ischemic Heart Diseases)
08/2015 - 07/2002
10Thrombosis (Thrombus)
01/2015 - 07/2002
9Hypertension (High Blood Pressure)
07/2012 - 02/2003
9Infection
06/2011 - 10/2005
8Diabetes Mellitus
08/2015 - 04/2006
8Inflammation
05/2009 - 02/2003
6Necrosis
09/2008 - 01/2003
5Coronary Disease (Coronary Heart Disease)
01/2012 - 02/2003
4Intracranial Hemorrhages (Intracranial Hemorrhage)
07/2007 - 10/2005
3Heart Diseases (Heart Disease)
01/2015 - 12/2010
3Kidney Diseases (Kidney Disease)
10/2014 - 04/2006
3Ventricular Tachycardia
07/2014 - 08/2010
3Chest Pain (Chest Pains)
04/2014 - 09/2013
3Hyperglycemia
06/2010 - 06/2006
3Pathologic Constriction (Stenosis)
04/2010 - 08/2004
2Atrial Fibrillation
06/2015 - 01/2015
2Vascular Diseases (Vascular Disease)
12/2014 - 04/2013
2Cardiac Sudden Death (Sudden Cardiac Arrest)
07/2014 - 08/2010
2Peripheral Arterial Disease
04/2013 - 09/2009
2Fibrosis (Cirrhosis)
10/2012 - 01/2012
2Cardiac Arrhythmias (Arrythmia)
10/2007 - 04/2007
2Infarction
06/2006 - 07/2002
2Renal Insufficiency (Renal Failure)
06/2006 - 02/2003
1Transient Ischemic Attack
11/2015

Drug/Important Bio-Agent (IBA)

34Biological Markers (Surrogate Marker)IBA
06/2014 - 11/2002
23Brain Natriuretic Peptide (Natrecor)FDA Link
10/2014 - 02/2002
22Neurofibromin 2 (Merlin)IBA
10/2015 - 06/2006
22ranolazineFDA Link
08/2015 - 06/2006
21Enoxaparin (Lovenox)FDA LinkGeneric
09/2010 - 06/2002
20C-Reactive ProteinIBA
09/2011 - 04/2002
17TroponinIBA
04/2014 - 07/2002
16Troponin IIBA
10/2015 - 04/2002
15Heparin (Liquaemin)FDA LinkGeneric
09/2010 - 02/2005
11atorvastatin (Lipitor)FDA Link
06/2011 - 05/2005
11Pravastatin (Pravachol)FDA LinkGeneric
06/2011 - 05/2005
11tirofiban (Aggrastat)FDA Link
09/2008 - 07/2002
10clopidogrel (Plavix)FDA Link
03/2014 - 12/2005
10Glycoproteins (Glycoprotein)IBA
01/2014 - 11/2002
8Natriuretic PeptidesIBA
10/2014 - 01/2003
6Troponin T (T, Troponin)IBA
09/2011 - 07/2002
5ThrombinFDA Link
11/2015 - 04/2005
5SCH 530348IBA
12/2014 - 09/2009
5Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
06/2014 - 11/2005
5pro-brain natriuretic peptide (1-76)IBA
06/2013 - 11/2005
5CreatinineIBA
03/2013 - 11/2003
5CalciumIBA
10/2007 - 11/2005
4Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2012 - 05/2005
4N(2)-(3-trifluoromethylphenyl)guanineIBA
11/2011 - 07/2002
4Glucose (Dextrose)FDA LinkGeneric
06/2010 - 06/2006
4CD40 Ligand (CD40L)IBA
10/2008 - 09/2003
4MB Form Creatine KinaseIBA
02/2007 - 07/2002
3Thrombin Receptors (Thrombin Receptor)IBA
11/2015 - 12/2014
3PAR-1 ReceptorIBA
11/2015 - 09/2009
3AnticoagulantsIBA
06/2015 - 04/2005
3trandolapril (Mavik)FDA LinkGeneric
06/2014 - 03/2007
3StreptokinaseFDA Link
04/2013 - 07/2007
3prasugrelIBA
01/2012 - 06/2009
31-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
09/2011 - 04/2006
3Peroxidase (Myeloperoxidase)IBA
10/2010 - 05/2007
3Thromboplastin (Tissue Factor)IBA
03/2009 - 04/2005
3Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
11/2007 - 02/2003
3SodiumIBA
10/2007 - 06/2006
3Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
09/2007 - 05/2005
3eptifibatide (Integrilin)FDA Link
06/2006 - 05/2006
2thienopyridineIBA
11/2015 - 06/2009
2saxagliptinFDA Link
08/2015 - 10/2014
2AdrenomedullinIBA
04/2014 - 01/2012
2Phospholipases (Phospholipase)IBA
11/2013 - 09/2011
2Secretory Phospholipases A2IBA
11/2013 - 09/2011
2Carrier Proteins (Binding Protein)IBA
11/2013 - 08/2006
2valsartan (Vals)FDA Link
06/2013 - 08/2010
2aliskirenFDA Link
06/2013 - 08/2010
2glucuronyl glucosamine glycan sulfate (Vessel)IBA
03/2013 - 08/2004
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
10/2012 - 09/2009
2Galectin 3 (LGALS3)IBA
10/2012 - 01/2012
2LDL CholesterolIBA
04/2012 - 06/2007
2NeopterinIBA
06/2011 - 06/2007
2Growth Differentiation Factor 15IBA
01/2011 - 10/2010
2Hemoglobins (Hemoglobin)IBA
03/2009 - 04/2005
2Dihydrotachysterol (AT 10)IBA
10/2008 - 07/2004
2Simvastatin (Zocor)FDA LinkGeneric
09/2008 - 07/2006
2FibrinIBA
06/2008 - 07/2007
2Fibrinolytic Agents (Antithrombotic Agents)IBA
10/2006 - 06/2006
2bivalirudin (Angiomax)FDA Link
06/2006 - 05/2006
2S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA
03/2005 - 08/2004
2tenecteplaseFDA Link
07/2004 - 04/2004
2orbofibanIBA
07/2004 - 02/2003
1Warfarin (Coumadin)FDA LinkGeneric
06/2015

Therapy/Procedure

11Thrombolytic Therapy
09/2010 - 11/2004
3Stents
12/2014 - 05/2006